NIH Guide for Grants and Contracts
September 20, 2019
Weekly NIH Funding Opportunities and Notices

General Notices

Notice of Changes to Funding Opportunities

  • Notice of Clarification of Product Integrity Information in PA-18-817 "Administrative Supplements for Research on Dietary Supplements (Admin Supp - Clinical Trial Not Allowed)"
    (NOT-OD-19-145)
    Office of Dietary Supplements
    John E. Fogarty International Center
    National Center for Complementary and Integrative Health
    National Cancer Institute
    National Eye Institute
    National Heart, Lung, and Blood Institute
    National Institute on Aging
    National Institute on Alcohol Abuse and Alcoholism
    National Institute of Allergy and Infectious Diseases
    National Institute of Arthritis and Musculoskeletal and Skin Diseases
    National Institute of Biomedical Imaging and Bioengineering
    Eunice Kennedy Shriver National Institute of Child Health and Human Development
    National Institute on Deafness and Other Communication Disorders
    National Institute of Dental and Craniofacial Research
    National Institute of Diabetes and Digestive and Kidney Diseases
    National Institute of Environmental Health Sciences
    Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs

Notices of Intent to Publish

Funding Opportunities

  • Research on biopsychosocial factors of social connectedness and isolation on health, wellbeing, illness, and recovery (R01 Clinical Trials Not Allowed)
    (PAR-19-373)
    NIH Basic Behavioral and Social Science Opportunity Network
    National Center for Complementary and Integrative Health
    National Cancer Institute
    National Eye Institute
    National Institute on Aging
    National Institute on Alcohol Abuse and Alcoholism
    National Institute of Arthritis and Musculoskeletal and Skin Diseases
    Eunice Kennedy Shriver National Institute of Child Health and Human Development
    National Institute on Drug Abuse
    National Institute on Deafness and Other Communication Disorders
    National Institute of Mental Health
    National Institute on Minority Health and Health Disparities
    National Institute of Neurological Disorders and Stroke
    National Institute of Nursing Research
    Office of Behavioral and Social Science Research
    Application Receipt Date(s): March 17, 2020; March 17, 2021,

  • Bioinformatics Interdisciplinary Predoctoral Fellowship in Diabetes, Endocrinology and Metabolic Diseases (F31)
    (PAR-19-378)
    National Institute of Diabetes and Digestive and Kidney Diseases
    Application Receipt Date(s): Standard dates apply All applications are due, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

  • Bioinformatics Interdisciplinary Postdoctoral Fellowship in Diabetes, Endocrinology and Metabolic Diseases (F32)
    (PAR-19-379)
    National Institute of Diabetes and Digestive and Kidney Diseases
    Application Receipt Date(s): Standard dates apply All applications are due, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

  • Initiative to Maximize Research Education in Genomics: Diversity Action Plan (R25)
    (PAR-19-380)
    National Human Genome Research Institute
    Application Receipt Date(s): January 25, 2020, January 25, 2021, January 25, 2022 (new, renewal, revision applications); January 25, May 25, or Sept 25 of years 2020, 2021, 2022 (resubmission applications). All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

  • Patient Activation for Self-Management of Chronic Conditions (R01 Clinical Trial Optional)
    (PAR-19-381)
    National Institute of Nursing Research
    Application Receipt Date(s): New Applications: June 5, 2020; February 5, 2021; June 5, 2021; February 5, 2022; June 5, 2022; February 5, 2023 Renewal/Resubmission Applications: March 5, 2021; July 5, 2021; March 5, 2022; July 5, 2022; March 5, 2023 All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s) Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

  • Patient Activation for Self-Management of Chronic Conditions (R21 Clinical Trial Optional)
    (PAR-19-382)
    National Institute of Nursing Research
    Application Receipt Date(s): New Applications- June 16, 2020; February 16, 2021; June 16, 2021; February 16, 2022; June 16, 2022; February 16, 2023 Resubmissions- March 16, 2021; July 16, 2021; March 16, 2022; July 16, 2022; March 16, 2023 All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s) Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

  • Innovative Programs to Enhance Research Training (IPERT) (R25 - Independent Clinical Trial Not Allowed)
    (PAR-19-383)
    National Institute of General Medical Sciences
    Application Receipt Date(s): October 31, 2019; October 15, 2020; October 15, 2021, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.

  • Research on biopsychosocial factors of social connectedness and isolation on health, wellbeing, illness, and recovery (R01 Basic Experimental Studies with Humans Required)
    (PAR-19-384)
    NIH Basic Behavioral and Social Science Opportunity Network
    National Center for Complementary and Integrative Health
    National Cancer Institute
    National Eye Institute
    National Institute on Aging
    National Institute on Alcohol Abuse and Alcoholism
    Eunice Kennedy Shriver National Institute of Child Health and Human Development
    National Institute on Drug Abuse
    National Institute on Deafness and Other Communication Disorders
    National Institute of Mental Health
    National Institute on Minority Health and Health Disparities
    National Institute of Neurological Disorders and Stroke
    National Institute of Nursing Research
    Office of Behavioral and Social Science Research
    Application Receipt Date(s): March 17, 2020; March 17, 2021

  • Dementia Care: Home- and Community-Based Services (HCBS) (R01 Clinical Trial Not Allowed)
    (RFA-AG-20-037)
    National Institute on Aging
    Application Receipt Date(s): February 3, 2020 No late applications will be accepted for this Funding Opportunity Announcement.

  • Dementia Care: Home- and Community-Based Services (HCBS) (R21 Clinical Trial Not Allowed)
    (RFA-AG-20-038)
    National Institute on Aging
    Application Receipt Date(s): February 3, 2020, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. No late applications will be accepted for this funding opportunity announcement.

  • Cancer Intervention and Surveillance Modeling Network (CISNET) (U01 Clinical Trial Not Allowed)
    (RFA-CA-19-054)
    National Cancer Institute
    Application Receipt Date(s): December 10, 2019 All applications are due by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on the listed date(s). No late applications will be accepted for this Funding opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

  • Research Networks for the Study of Recovery Support Services for Persons Treated with Medications for Opioid Use Disorder (R24 Clinical Trial Optional)
    (RFA-DA-20-014)
    National Institute on Drug Abuse
    Application Receipt Date(s): November 19, 2019 by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. No late applications will be accepted for this Funding Opportunity Announcement.

  • Targeting Inflammasomes in Substance Abuse and HIV (R01 Clinical Trial Not Allowed)
    (RFA-DA-20-026)
    National Institute on Drug Abuse
    Application Receipt Date(s): Only accepting applications for the AIDS Application Due Date(s) listed below.

  • Pregnancy as a Vulnerable Time Period for Women's Health (R01 Clinical Trial Not Allowed)
    (RFA-ES-20-003)
    National Institute of Environmental Health Sciences
    Office of Research on Women's Health
    Application Receipt Date(s): December 6, 2019 by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.

  • Innovative Epidemiologic Approaches for Understanding Long-term Health Outcomes of HIV-exposed Uninfected (HEU) Populations (R61/R33 Clinical Trial Not Allowed)
    (RFA-HD-20-008)
    Eunice Kennedy Shriver National Institute of Child Health and Human Development
    National Institute of Mental Health
    Application Receipt Date(s): December 2, 2019

  • Non-invasive Diagnostics to Improve Gynecologic Health (R43/R44 Clinical Trial Optional)
    (RFA-HD-20-019)
    Eunice Kennedy Shriver National Institute of Child Health and Human Development
    Application Receipt Date(s): December 10, 2019, by 5:00 PM local time of applicant organization. No late applications will be accepted for this Funding Opportunity Announcement